BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 5:33:00 PM | Browse: 1078 | Download: 1025
Publication Name World Journal of Gastroenterology
Manuscript ID 5382
Country Poland
Received
2013-09-04 16:13
Peer-Review Started
2013-09-05 08:33
To Make the First Decision
2013-11-13 14:11
Return for Revision
2013-10-15 14:07
Revised
2013-11-05 18:20
Second Decision
2013-12-05 19:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-06 12:03
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-06 09:52
Publish the Manuscript Online
2014-01-20 17:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability
Manuscript Source Invited Manuscript
All Author List Danuta Owczarek, Dorota Cibor, Mikołaj K Głowacki, Tomasz Rodacki and Tomasz Mach
Funding Agency and Grant Number
Corresponding Author Danuta Owczarek, MD, PhD, Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Kraków, Poland 5 Śniadeckich St, 31-531 Krakow, Poland. owczarek@su.krakow.pl
Key Words Crohn’s disease; Hypercoagulation; Risk factors; Thrombosis; Ulcerative colitis
Core Tip Thromboembolic events (TE) in inflammatory bowel diseases (IBD) patients are often overlooked. They affect both the venous and arterial systems. The inflammatory process initiates clotting, impairs the fibrinolytic system and decreases the activity of natural anticoagulation mechanisms. Depression of anticoagulation mechanisms not only increases thrombosis, but also potentiates the inflammatory process. The objective of the present report is to demonstrate the high significance of a problem posed by hypercoagulability in IBD patients based on TE epidemiology, and to present abnormalities in the hemostatic system.
Publish Date 2014-01-20 17:10
Citation Owczarek D, Cibor D, G?owacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014; 20(1): 53-63
URL http://www.wjgnet.com/1007-9327/full/v20/i1/53.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i1.53
Full Article (PDF) WJG-20-53.pdf
Full Article (Word) WJG-20-53.doc
Manuscript File 5382-Review.docx
Answering Reviewers 5382-Answering reviewers.pdf
Copyright License Agreement 5382-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5382-Language certificate.pdf
Peer-review Report 5382-Peer review(s).pdf
Scientific Editor Work List 5382-Scientific editor work list.doc